Straits Times Index
3,194.08 +6.42 (+0.20%) Nikkei
37,219.45 -860.25 (-2.26%) Hang Seng
16,385.87 0.00 (0.00%) FTSE 100
7,877.05 +29.06 (+0.37%) Bitcoin USD
61,982.30 +509.88 (+0.83%) CMC Crypto 200
1,293.13 +407.59 (+45.98%)
Pfizer Inc. (PFE)
After hours:
- Benzinga
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost in line with estimates. First quarter results came shortly after JNJ’s expansion in the cardiovascular space with the $13.1 billion acquisition of heart device firm Shockwave Medical Inc (NASDAQ: SWAV). First Quarter Highlights For the period ended in March, the healthcare company posted a revenue
- Zacks
Why the Market Dipped But Pfizer (PFE) Gained Today
Pfizer (PFE) closed the most recent trading day at $25.91, moving +0.19% from the previous trading session.
- Insider Monkey
10 Micro-Cap Healthcare Stocks Insiders Are Buying
In this article, we will take a detailed look at the 10 Micro-Cap Healthcare Stocks Insiders Are Buying. For a quick overview of such stocks, read our article 5 Micro-Cap Healthcare Stocks Insiders Are Buying. Investors have always been interested in the connection between insider buying and stock returns. Over the past several years there’s been a huge influx […]
